Ventilator-associated pneumonia: Update on etiology, prevention, and management

Current Infectious Disease Reports

Volumn 13, Issue 3, 2011, Pages 287-295

  Rewa, Oleksa ^a   Muscedere, John ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Diagnosis; Etiology; Intensive care unit; Management; Nosocomial infections; Prevention; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHLORHEXIDINE; PROBIOTIC AGENT; PROCALCITONIN; SODIUM CHLORIDE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; BREATHING EXERCISE; DRUG EFFICACY; EARLY INTERVENTION; ENDOTRACHEAL TUBE; EQUIPMENT DESIGN; ESCHERICHIA COLI; HAND WASHING; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INDIVIDUALIZATION; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LUNG LAVAGE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MOUTH HYGIENE; NONINVASIVE VENTILATION; PATHOGENESIS; PATIENT CARE; PATIENT POSITIONING; PATIENT SAFETY; POSITIVE END EXPIRATORY PRESSURE; PROTECTIVE CLOTHING; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; TRACHEAL ASPIRATION PROCEDURE; TRACHEOBRONCHIAL TOILET; TRACHEOSTOMY; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 79956197260     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0177-9     Document Type: Article

References (51)

1. M Valencia A Torres 2009 Ventilator associated pneumonia Curr Opin Crit Care. 15 30 35 19186407 10.1097/MCC.0b013e3283220e78
2. N Safdar C Dezfulian HR Collard S Saint 2005 Clinical and economic consequences of ventilator-associated pneumonia: a systematic review Crit Care Med. 33 2184 2193 16215368 10.1097/01.CCM.0000181731.53912.D9 (Pubitemid 41437469)
3. J Muscedere A Day DK Heyland 2010 Mortality, attributable mortality and time to clinical event analysis as endpoints for trials of ventilator associated pneumonia and hospital acquired pneumonia Clin Inf Dis. 51 S120 5 10.1086/653060
4. SM Koenig JD Truwit 2006 Ventilator-associated pneumonia: diagnosis, prevention and treatment Clin Micro Review. 19 637 657 10.1128/CMR.00051-05 (Pubitemid 44582975)
5. J Chastre JY Fagon 2002 Ventilator-associated pneumonia Am J Respir Crit Care Med. 165 867 903 11934711 (Pubitemid 34774654)
6. L Lorente 2008 Nonpharmacologic Measures to Prevent Ventilator-Associated Pneumonia Clin Pulm Med. 15 63 70 10.1097/CPM.0b013e31816728ac This recent review examines the various nonpharmacological measures used to prevent VAP and the evidence surrounding each of these interventions (Pubitemid 351416784)
7. L Holzapfel C Chastang G Demingeon, et al. 1999 A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia Am J Respir Crit Care Med. 159 695 701 10051239 1:STN:280:DyaK1M7mtVOksA%3D%3D (Pubitemid 29137762)
8. M Kollef B Afessa A Anzueto, et al. 2008 Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial JAMA. 300 805 813 18714060 10.1001/jama.300.7.805 1:CAS:528:DC%2BD1cXhtVWkurjO This article describes the first RCT examining the role of silver-coated endotracheal tubes and their role in the prevention of VAP
9. AF Shorr MD Zilberberg M Kollef 2009 Coast-effectiveness analysis of silver-coated endotracheal tubes to reduce the incidence of ventilator- associated pneumonia Infect Control Hosp Epidemiol. 30 759 763 19538095 10.1086/599005 An analysis of the cost effectiveness of the use of silver-coated endotracheal tubes in the prevention of VAP with the aid of a theoretical model
10. PJ Young S Pakeerathan MC Blunt S Subramanya 2006 A low-volume, low-pressure tracheal tube reduces pulmonary aspiration Crit Care Med. 34 632 639 16505646 10.1097/01.CCM.0000201406.57821.5B
11. A Dullenkopf A Geber M Weiss 2003 Fluid leakage past tracheal tube cuffs: evaluation of the new microcuff endotracheal tube Int Care Med. 29 1849 1853 10.1007/s00134-003-1933-6 (Pubitemid 37373839)
12. TaperGuard™ Endotracheal Tube FDA 510(k) Premarket Notification. Available at http://www.accessdata.fda.gov/cdrh-docs/pdf9/K090352.pdf. Accessed October 2010.
13. MH Dave A Frotzler N Spielmann C Madjdpour M Weiss 2010 Effect of tracheal tube cuff shape on fluid leakage across the cuff: an in vitro study Brit J Anaes. 105 538 543 10.1093/bja/aeq202 1:STN:280:DC%2BC3cfhvFymsQ%3D%3D This recent paper demonstrates that in an in vitro study, polyurethane cuffs showed less leakage than PVC cuffs. The investigators also demonstrated that tapered cuffs were not inferior to cylindrical cuffs, and may in fact be superior to cylindrical cuffs in decreasing fluid leakage past the cuffs
14. L Lorente M Lecuona A Jimenez ML Mora A Sierra 2007 Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia Am J Respir Crit Care Med. 176 1079 83 17872488 10.1164/rccm.200705- 761OC (Pubitemid 350223753)
15. C Dezfulian K Shonjania H Collard, et al. 2005 Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis Am J Med. 118 11 18 15639202 10.1016/j.amjmed.2004.07.051 (Pubitemid 40082451)
16. JC Lacherade B De Jonghe P Guenzennec 2010 Intermittent subglottic secretion drainage and ventilator-associated pneumonia: a multicenter trial Am J Respir Crit Care Med. 182 910 917 20522796 10.1164/rccm.200906-0838OC
17. E Bouza MJ Perez P Munoz, et al. 2008 Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in post-operative period of major heart surgery Chest. 134 938 946 18641114 10.1378/chest.08-0103
18. P Caruso S Denari SAL Ruiz SE Demarzo D Deheinzelin 2009 Saline instillation before tracheal suctioning decreases the incidence of ventilator-associated pneumonia Crit Care Med. 37 32 38 19050607 10.1097/CCM.0b013e3181930026 This article examines the effect of saline instillation before suction on VAP. The investigators determined that with saline instillation, incidence of VAP was decreased
19. F Manzano E Fernandez-Mondejar M Colmenero, et al. 2008 Positive-end expiratory pressure reduces incidence of ventilator-associated pneumonia in non hypoxemic patients Crit Care Med. 36 2225 2231 18664777 10.1097/CCM. 0b013e31817b8a92 This paper examined the effects of PEEP versus no PEEP on VAP, and determined that minimal amounts of PEEP-regardless of the oxygenation of intubated patients-decreased the incidence of VAP
20. P Terragni M Antonelli R Fumagalli, et al. 2010 Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients a randomized controlled trial JAMA. 303 1483 1489 20407057 10.1001/jama.2010.447 1:CAS:528:DC%2BC3cXltlCgsbY%3D This article describes a 600-patient, multicenter, Italian, RCT that examined the role of early tracheostomy for the prevention of VAP. Investigators determined that early tracheostomy versus late tracheostomy did not prevent the development of VAP
21. S Sud M Sud JO Friedrich NKJ Adhikari 2008 Effect of mechanical ventilation in the prone position on clinical outcomes in patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis CMAJ. 178 1153 1161 18427090 (Pubitemid 351580074)
22. R Tiruvoipati M Bangash B Manktelow GJ Peek 2008 Efficacy of prone ventilation in adult patients with acute respiratory failure: a meta-analysis J Crit Care. 23 101 110 18359427 10.1016/j.jcrc.2007.09.003 A meta-analysis of five studies examining the effect of prone ventilation in patients. The authors did not find any reduction in mortality, pneumonia, or length of ICU stay with prone ventilation, but did find improved oxygenation (Pubitemid 351400348)
23. T Staudinger A Bojic U Holzinger, et al. 2010 Continuous lateral rotation therapy to prevent ventilator-associated pneumonia Crit Care Med. 38 486 490 19789440 10.1097/CCM.0b013e3181bc8218 The authors of this prospective randomized trial examined the effect of continuous lateral rotation to prevent VAP. They found that it did reduce VAP, but was also technically difficult and at times not tolerated by patients
24. AM de Smet JA Kluytmans BS Cooper, et al. 2009 Decontamination of the digestive tract and oropharynx in ICU patients N Engl J Med. 360 20 31 19118302 10.1056/NEJMoa0800394 The authors of this clinical trial examined the role of decontamination of the digestive tract and oropharynx in ICU patients. They found a 3.5% reduction in mortality in patients with selective decontamination of the digestive tract, and a 2.9% reduction in mortality in patients with selective oral decontamination at 28 days
25. EY Chan A Ruest M O'Meade, et al. 2007 Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis BMJ. 10.1136/bmj.39136.528160.BE (Pubitemid 46724331)
26. H Tantipong C Morkchareonpong S Jaiyindee V Thamlikitkul 2008 Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia Inf Cont Hosp Epidemiol. 29 131 136 10.1086/526438 The authors of this study determined that oral decontamination with 2% chlorhexidine is associated with a decreased incidence of VAP (Pubitemid 351269208)
27. ME Falagas II Siempos IA Bliziotis A Michalopoulos 2006 Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials Critical Care. 10 R123 10.1186/cc5032 16934148 10.1186/cc5032 (Pubitemid 47086878)
28. JA Claridge NM Edwards J Swanson, et al. 2007 Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: results of a double-blind randomized study Surg Inf. 7 83 90 10.1089/sur.2006.042 (Pubitemid 46598298)
29. II Siempos TK Ntaidou ME Falagas 2010 Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials Crit Care Med. 38 954 962 20016381 10.1097/CCM.0b013e3181c8fe4b This recent meta-analysis depicts how probiotics may be associated with decreased incidence of VAP
30. Institute for Healthcare Improvement Ventilator Bundle available at: http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/Changes/ ImplementtheVentilatorBundle.htm. Accessed November 2010.
31. Safer Health Care Now Ventilator Associated Pneumonia Prevention Bundle available at: http://www.saferhealthcarenow.ca/EN/Interventions/VAP/Pages/gsk. aspx. Accessed November 2010.
32. E Tejerina A Esteban P Fernandez-Segoviano, et al. 2010 Accuracy of clinical definitions of ventilator-associated pneumonia: comparison of autopsy findings J Crit Care. 25 62 68 19592209 10.1016/j.jcrc.2009.05.008 This recent paper compared the accuracy of clinical and microbiological diagnostic criteria with the autopsy diagnosis of VAP. Clinical criteria were found to have poor sensitivities and specificities for the diagnosis of VAP, but did improve with microbiological confirmation
33. DK Heyland D Cook P Dodek J Muscedere A Day 2006 A randomized trial of diagnostic techniques for ventilator-associated pneumonia N Engl J Med. 355 2619 30 10.1056/NEJMoa052904 1:CAS:528:DC%2BD28XhtlGhtLvI (Pubitemid 44969121)
34. E Bouza M Torres C Radice, et al. 2007 Direct E-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia Clin Inf Dis. 44 3 82 387 This study examined the effect of E-test for the treatment of VAP. E-test was shown to improve antibiotic use in the treatment of VAP
35. P Ramirez MA Garcia M Ferrer, et al. 2008 Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia Eur Respir J. 31 356 362 17959634 10.1183/09031936.00086707 1:CAS:528:DC%2BD1cXit12hu7c%3D This is an important article about examining CRP and PCT levels in making the diagnosis of VAP. The authors arrive at a clinical decision-making tool involving PCT for the diagnosis of VAP
36. F Duflo R Debon G Monneret J Bienvenu, et al. 2002 Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia Anesthesiology. 96 74 79 11753005 10.1097/00000542-200201000-00018 1:CAS:528:DC%2BD38XntFejsg%3D%3D (Pubitemid 34032485)
37. S Gibot A Cravoisy B Levy, et al. 2004 Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia N Engl J Med. 350 451 8 14749453 10.1056/NEJMoa031544 1:CAS:528:DC%2BD2cXos1Sitw%3D%3D (Pubitemid 38133765)
38. NJ Anand S Zuick J Klesney-Tait MH Kollef 2009 Diagnostic implications of soluble triggering receptor expressed on myeloid-1 cells in BAL fluid in patients with pulmonary infiltrates in the ICU Chest. 135 641 647 18849395 10.1378/chest.08-1829 This prospective cohort study found that sTREM-1 may have minimal diagnostic value for VAP
39. G Horonenko JC Hoyt RA Robbins, et al. 2007 Soluble triggering receptor expressed on myeloid-1 cells is increased with patients with ventilator associated pneumonia: A preliminary report Chest. 132 58 63 17505044 10.1378/chest.06-2731 1:CAS:528:DC%2BD2sXovFKltbc%3D This article describes a prospective study that found that sTREM-1 may be useful in diagnosing VAP (Pubitemid 47068203)
40. GJ Oudhuis J Beuving D Bergmans, et al. 2009 Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia Intensive Care Med. 35 1265 1270 19343323 10.1007/s00134-009-1463-y 1:CAS:528:DC%2BD1MXnsVWmsb4%3D This observational study found that sTREM-1 in BAL is not useful in the diagnosis of VAP
41. EL Kuti AA Patel CI Coleman 2008 Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infections: a meta-analysis J Crit Care 23 91 100 18359426 10.1016/j.jcrc.2007.08.007 Inappropriate initial antibiotic therapy is associated with increased mortality in VAP. (Pubitemid 351400347)
42. AR Joffe J Muscedere JC Marschall Y Su DK Heyland 2008 The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study J Crit Care. 23 82 90 18359425 10.1016/j.jcrc.2007.12.006 This observational study found that targeted antibiotic therapy for VAP was associated with less antibiotic use and was not associated with any increased harm (Pubitemid 351400353)
43. DK Heyland P Dodek J Muscedere 2008 Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia Crit Care Med. 36 737 744 18091545 10.1097/01.CCM.0B013E31816203D6 Monotherapy is not inferior to combination therapy for the treatment of VAP. There is a trend for patients with late-onset VAP to do better with combination therapy versus monotherapy
44. DE Craven A Chroneou N Zias KI Hjalmarson 2009 Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes CHEST. 135 521 528 18812452 10.1378/chest.08-1617 The authors report that VAT may be an important risk factor for the development of VAP, and treatment of VAT may result in a lower incidence of VAP.
45. • Nseir S, Favory R, Josefowicz J, et al.: Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study, Critical Care 2008, 12:R62 doi: 10.1186/cc6890. Available online at http://ccforum.com/content/12/3/R62. Accessed October 2010. In patients with VAT, antimicrobial treatment is associated with lower rates of VAP and ICU mortality. (Pubitemid 351753656)
46. LB Palmer GC Smaldone JJ Chen, et al. 2008 Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit Crit Care Med. 36 2008 2013 18552684 10.1097/CCM.0b013e31817c0f9e 1:CAS:528: DC%2BD1cXotVyls7k%3D This article describes a double-blind RCT examining the role of aerosolized antibiotics and VAT in the ICU. The authors found that with aerosolized antibiotics, there was a significant reduction in VAP, which facilitated weaning and decreased administration of systemic antibiotics
47. DS Burgess 2009 Curbing resistance development: maximizing the utility of available agents J Manag Care Pharm. 15 S5 S9 19505173
48. AM Nicasio KJ Eagye DP Nicolau, et al. 2010 Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia J Crit Care. 25 69 77 19427167 10.1016/j.jcrc.2009.02.014 1:CAS:528:DC%2BC3cXksVyksbc%3D
49. J Chastre M Wolff JY Fagon, et al. 2003 Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial JAMA. 290 2588 2598 14625336 10.1001/jama.290.19.2588 1:CAS:528: DC%2BD3sXpt1Cmu7g%3D (Pubitemid 37443289)
50. D Stolz N Smyrnios P Eggimann, et al. 2009 Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study Eur Respir J. 34 1364 1375 19797133 10.1183/09031936.00053209 1:CAS:528: DC%2BC3cXltVWrtw%3D%3D This article describes a multicenter RCT that found following PCT levels reduces patient exposure to antibiotics in the treatment of VAP.
51. L Bouadama CE Luyt F Tubach, et al. 2010 Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomized controlled trial Lancet. 375 463 74 10.1016/S0140- 6736(09)61879-1 This article describes a large, multicenter, randomized trial examining the role of PCT in guiding continued antimicrobial therapy for VAP. The authors found that by using PCT with specific cut-off criteria, the duration of antimicrobial therapy could be shortened with no adverse effects.